Volume 25, Number 11—November 2019
Dispatch
Preventing Sexual Transmission of Zika Virus Infection during Pregnancy, Puerto Rico, USA, 20161
Table 1
Characteristic | Received counseling on condom use to prevent Zika, n = 2,229† |
||
---|---|---|---|
% Patients (95% CI)‡ | Crude PR (95% CI) | Adjusted PR (95% CI)§ | |
Age, y | |||
<19 | 89.7 (85.6–92.7) | 1.17 (1.09–1.26) | 1.10 (1.03–1.18) |
20–34 | 87.3 (85.7–88.7) | 1.13 (1.06–1.21) | 1.07 (1.01–1.13) |
>35 |
81.5 (77.0–85.3) |
Referent¶ |
Referent¶ |
Education level | |||
High school or less | 86.3 (83.5–88.6) | 1.02 (0.99–1.05) | 0.99 (0.96–1.03) |
More than high school |
87.1 (85.4–88.5) |
Referent |
Referent |
Marital status during pregnancy | |||
Unmarried | 86.2 (84.4–87.8) | 1.03 (0.99–1.07) | 0.98 (0.95–1.01) |
Married |
88.0 (85.5–90.1) |
Referent |
Referent |
Prenatal WIC program participation | |||
Yes, did not receive a Zika prevention kit | 80.2 (75.4–84.3) | 1.13 (1.02–1.24) | 1.14 (1.02–1.26) |
Yes, received a Zika prevention kit | 90.3 (88.9–91.5) | 1.27 (1.16–1.38) | 1.28 (1.17–1.40) |
No |
70.6 (64.0–76.5) |
Referent |
Referent |
Sexually active during pregnancy | |||
Yes | 87.0 (85.5–88.3) | Referent | Referent |
No | 86.3 (83.1–89.0) | 1.00 (0.96–1.03) | 0.99 (0.96–1.03) |
*PR, prevalence ratio; WIC, Special Supplemental Nutrition Program for Women, Infants, and Children.
†Unweighted sample size.
‡Adjusted weighted percentage.
§All prevalence and prevalence ratio estimates were adjusted for maternal age and education, marital status, prenatal WIC participation, sexual activity during pregnancy, infant birth month, and region.
¶Adjusted p value (<0.01) for linear trend based on maternal age.
1Preliminary results from this study were presented at the 2018 American Public Health Association Annual Meeting in San Diego, California, USA, November 10–14, 2018.
Page created: October 15, 2019
Page updated: October 15, 2019
Page reviewed: October 15, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.